Pfizer Stock

Pfizer Operating Cash Flow

The Operating Cash Flow of Pfizer (PFIZER.NS) as of Aug 7, 2026 is 6.60 B INR. In the previous year, Operating Cash Flow was 2.57 B INR — a change of 156.87% (higher).

Operating Cash Flow

6.60 BINR

YoY

156.87%

Last updated:

Operating Cash Flow of Pfizer is 2026 6.60 B INR. Operating Cash Flow of Pfizer was 2025 2.57 B INR. It decreases by 156.87% higher compared to the previous year.
Access this data via the Eulerpool API

Pfizer Stock analysis

What does Pfizer do? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pfizer stock

Operating Cash Flow of Pfizer is 6.60 B INR in 2026.

Operating Cash Flow of Pfizer changed from 2.57 B INR to 6.60 B INR, representing a 156.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Pfizer since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Pfizer historically and in real time.

Access this data via the Eulerpool API

Cash Flow — Pfizer

All Key Metrics — Pfizer